Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.

Neurology - 8 Jul 2014

Koene Saskia, de Laat Paul, van Tienoven Doorlène H, Vriens Dennis, Brandt André M, Sweep Fred C G J, Rodenburg Richard J T, Donders A Rogier T, Janssen Mirian C H, Smeitink Jan A M

Abstract excerpt

OBJECTIVES: To determine the value of fibroblast growth factor 21 (FGF21), a recently discovered biomarker for mitochondrial disease, in predicting clinical disease severity and disease progression in adult carriers of the m.3243A>G mutation. METHODS: In the context of a national inventory, the h...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Progression
Share to Fibroblast Growth Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Leukocytes

Share to Mitochondrial Diseases

Share to Mitochondrial Encephalomyopathies

Share to Mitochondrial Myopathies

Source

Identifiers

PMID: 24907231
DOI: 10.1212/WNL.0000000000000578

Genes

FGF21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24907231-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.PMID 24907231Read ↗

Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variantSemantic proximity Read ↗

The West of Scotland Cohort of Mitochondrial Individuals with the m.3243A>G Variant: Variations in Phenotypes and Predictors of Disease Severity.Semantic proximity Read ↗

Noninvasive diagnosis of the 3243A > G mitochondrial DNA mutation using urinary epithelial cells.Semantic proximity Read ↗

The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm.Semantic proximity Read ↗

The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.Semantic proximity Read ↗

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.Semantic proximity Read ↗

Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factorsSemantic proximity Read ↗

The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype.Semantic proximity Read ↗

Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation.Semantic proximity Read ↗

FGF-21 as a Potential Biomarker for Mitochondrial DiseasesSemantic proximity Read ↗

Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA.Semantic proximity Read ↗

A case of 3243A>G mutation in mtDNA presenting as apparently idiopathic hyperCKemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.